mGluR2/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions
出版年份 2016 全文链接
标题
mGluR2/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions
作者
关键词
-
出版物
MOLECULAR PSYCHIATRY
Volume 22, Issue 11, Pages 1615-1625
出版商
Springer Nature
发表日期
2016-08-09
DOI
10.1038/mp.2016.129
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia
- (2015) Bruce J. Kinon et al. BIOLOGICAL PSYCHIATRY
- Stress Impairs Prefrontal Cortical Function via D1 Dopamine Receptor Interactions With Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
- (2015) Nao J. Gamo et al. BIOLOGICAL PSYCHIATRY
- Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder
- (2015) D Arion et al. MOLECULAR PSYCHIATRY
- Effect of metabotropic glutamate receptor-3 variants on prefrontal brain activity in schizophrenia: An imaging genetics study using multi-channel near-infrared spectroscopy
- (2015) Akihide Kinoshita et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?
- (2015) Meng-Lin Li et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Evaluation of relationship between GRM3 polymorphisms and cognitive function in schizophrenia of Han Chinese
- (2015) Ming Chang et al. PSYCHIATRY RESEARCH
- mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests
- (2014) Mira Lainiola et al. BEHAVIOURAL BRAIN RESEARCH
- Disrupted in Schizophrenia 1 Modulates Medial Prefrontal Cortex Pyramidal Neuron Activity Through cAMP Regulation of Transient Receptor Potential C and Small-Conductance K+ Channels
- (2014) Lynda El-Hassar et al. BIOLOGICAL PSYCHIATRY
- A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia
- (2014) AnnCatherine M Downing et al. BMC Psychiatry
- cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex
- (2014) Becky C. Carlyle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder
- (2014) Niamh L. O’Brien et al. PSYCHIATRIC GENETICS
- Association of GRM3 polymorphism with white matter integrity in schizophrenia
- (2014) Joanna Mounce et al. SCHIZOPHRENIA RESEARCH
- Comprehensive behavioral study of mGluR3 knockout mice: implication in schizophrenia related endophenotypes
- (2014) Ryuta Fujioka et al. Molecular Brain
- Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans
- (2013) N R Driesen et al. MOLECULAR PSYCHIATRY
- NMDA Receptors Subserve Persistent Neuronal Firing during Working Memory in Dorsolateral Prefrontal Cortex
- (2013) Min Wang et al. NEURON
- Nicotinic 7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex
- (2013) Y. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of disrupted in schizophrenia 1 (DISC1) in stress-induced prefrontal cognitive dysfunction
- (2013) N J Gamo et al. Translational Psychiatry
- Constellation of HCN Channels and cAMP Regulating Proteins in Dendritic Spines of the Primate Prefrontal Cortex: Potential Substrate for Working Memory Deficits in Schizophrenia
- (2012) Constantinos D. Paspalas et al. CEREBRAL CORTEX
- Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia
- (2012) Dor Mohammad Kordi-Tamandani et al. GENE
- Neuromodulation of Thought: Flexibilities and Vulnerabilities in Prefrontal Cortical Network Synapses
- (2012) Amy F.T. Arnsten et al. NEURON
- Positive association of Phencyclidine-responsive genes, PDE4A and PLAT, with schizophrenia
- (2011) Xiangdong Deng et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Activation of Group II Metabotropic Glutamate Receptors Inhibits Glutamatergic Transmission in the Rat Entorhinal Cortex via Reduction of Glutamate Release Probability
- (2011) S. Wang et al. CEREBRAL CORTEX
- Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia
- (2011) Jeffrey R. Bishop et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors
- (2011) Nao J. Gamo et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Neuronal basis of age-related working memory decline
- (2011) Min Wang et al. NATURE
- Upregulation of presynaptic mGluR2, but not mGluR3 in the epileptic medial perforant path
- (2011) Judith Rohde et al. NEUROPHARMACOLOGY
- Enhancement of CA3 hippocampal network activity by activation of group II metabotropic glutamate receptors
- (2011) J. Ster et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation
- (2010) E.A. Hackler et al. NEUROSCIENCE
- Absence of direct effects on the dopamine D2 receptor by mGluR2/3-selective receptor agonists LY 354,740 and LY 379,268
- (2010) John R. Zysk et al. SYNAPSE
- Differential Expression of Metabotropic Glutamate Receptors 2 and 3 in Schizophrenia: A Mechanism for Antipsychotic Drug Action?
- (2009) Subroto Ghose et al. AMERICAN JOURNAL OF PSYCHIATRY
- In Vitro and in Vivo Evidence for a Lack of Interaction with Dopamine D2 Receptors by the Metabotropic Glutamate 2/3 Receptor Agonists 1S,2S,5R,6S-2-Aminobicyclo[3.1.0]hexane-2,6-bicaroxylate Monohydrate (LY354740) and (-)-2-Oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic Acid (LY379268)
- (2009) M. J. Fell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Glutamate agonists for treating schizophrenia have affinity for dopamine D2Highand D3 receptors
- (2009) Philip Seeman et al. SYNAPSE
- Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex
- (2008) Carlo Colantuoni et al. Brain Structure & Function
- Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia
- (2008) Rainald Mössner et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia
- (2008) PJ Harrison et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Expression of a GRM3 Splice Variant is Increased in the Dorsolateral Prefrontal Cortex of Individuals Carrying a Schizophrenia Risk SNP
- (2008) Leah J Sartorius et al. NEUROPSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started